Clinical decision support systems (CDSS) are an essential component of the healthcare IT spectrum

A healthy body stays healthy due to all kinds of enzymes in the body being in proper balance. Excess of an enzyme can disturb balance while deficiency of another one can have the same effect

A CAGR of 7.8 per cent is expected for the forecast period between 2022 and 2027, bringing the total global cosmetic surgery market to USD 21.97 billion

Market Research Future (MRFR), in its “Medical Devices Market” report, states that the market can value at USD 6170.72 Bn at 22% CAGR by 2030

global microfluidic device market will touch a phenomenal valuation by 2027

The demand for self-diagnosing kits and devices has amplified as the number of coronavirus cases has improved around the world

The influenza vaccines market is expected to grow at a 6.53 percent CAGR by 2025, reaching USD 7,828.3 million

According to MRFR analysis, Biosimulation Market is expected to register a CAGR of 15.9% during the forecast period

allergy immunotherapy market in the global market will grow at a higher CAGR of 10.85% by the end of the forecasted period and account for a market share of approximately 4.32 billion by the end of the forecasted period from 2022 to 2027

It is estimated that the global vascular closure devices market is expected to register a CAGR ~ 6.8% during the forecast period

The global dental lasers market, as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period

Sinus is also called as chronic rhinosinusitis; it is a condition in which cavities around nasal known as (sinuses) get inflamed and swollen for weeks

The transthyretin amyloidosis market is expected to register a sturdy growth during the forecast period

According to the MRFR reports, the global minimally invasive cosmetic procedures market is projected to attain a valuation of USD 8,400.33 million by 2027

As per the reports by MRFR, the hemophilia treatment market is likely to project a robust CAGR of 6.10% during the review timeframe from 2022 to 2027